Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001451612-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 23, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
31,798
Total Value
$3,299,037.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 22, 2026 | Sale | 18,313 | $103.42 | $1,893,930.46 | 3,472,340 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Sale | 9,584 | $104.38 | $1,000,377.92 | 3,462,756 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Sale | 2,560 | $103.42 | $264,755.20 | 615,103 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Sale | 1,341 | $104.38 | $139,973.58 | 613,762 | Indirect | See footnote | View Details |